These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15597214)

  • 1. Translational research and the changing face of breast cancer.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S1-2. PubMed ID: 15597214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing the future shape of breast cancer diagnosis, prognosis and treatment.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S27-9. PubMed ID: 15597218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genomics and clinical research for breast cancer].
    Bertucci F; Birnbaum D
    Med Sci (Paris); 2012 Mar; 28 Spec No 1():14-8. PubMed ID: 22494651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding tumor profiling and assessing treatment.
    Hyams DM
    Manag Care; 2008 Jul; 17(7 Suppl 7):4-8; discussion 17-8. PubMed ID: 19093336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
    Kaufmann M; Pusztai L;
    Cancer; 2011 Apr; 117(8):1575-82. PubMed ID: 21472705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials design and treatment tailoring: general principles applied to breast cancer research.
    Therasse P; Carbonnelle S; Bogaerts J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):98-105. PubMed ID: 16431124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving decision-making in early breast cancer: who to treat and how?
    Llombart-Cussac A
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():15-24. PubMed ID: 19082929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic information in breast cancer care: helping patients utilize important information.
    Rosenzweig MQ; Rust D; Hoss J
    Clin J Oncol Nurs; 2000; 4(6):271-8. PubMed ID: 11899325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of prognostic profiling in breast cancer.
    Pusztai L
    Oncologist; 2008 Apr; 13(4):350-60. PubMed ID: 18448548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progesterone receptor isoforms: clinical significance in breast cancer.
    Fuqua SA; Cui Y
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S3-10. PubMed ID: 15597215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative biology: a new paradigm for tumor profiling, prognosis, and treatment.
    Heaton AH
    Manag Care; 2008 Jul; 17(7 Suppl 7):3; discussion 17-8. PubMed ID: 19097281
    [No Abstract]   [Full Text] [Related]  

  • 13. User-centered research on breast cancer patient needs and preferences of an Internet-based clinical trial matching system.
    Atkinson NL; Massett HA; Mylks C; Hanna B; Deering MJ; Hesse BW
    J Med Internet Res; 2007 May; 9(2):e13. PubMed ID: 17513284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards discovery-driven translational research in breast cancer.
    Celis JE; Moreira JM; Gromova I; Cabezon T; Ralfkiaer U; Guldberg P; Straten PT; Mouridsen H; Friis E; Holm D; Rank F; Gromov P
    FEBS J; 2005 Jan; 272(1):2-15. PubMed ID: 15634327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker research in breast cancer.
    Maxwell C
    Clin J Oncol Nurs; 2010 Dec; 14(6):771-83. PubMed ID: 21112854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing therapeutically developed assays.
    Kolesar JM
    Manag Care; 2008 Jul; 17(7 Suppl 7):9-12; discussion 17-8. PubMed ID: 19097282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A health plan's integration of molecular diagnostics and the impact on treatment pathways for quality care.
    Wong W
    Manag Care; 2008 Jul; 17(7 Suppl 7):13-6; discussion 17-8. PubMed ID: 19093337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for breast cancer and their use in the clinical setting.
    Kapoor A; Vogel VG
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):269-81. PubMed ID: 15877524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of breast cancer: the role of prognostic factors.
    Gradishar WJ
    Breast Cancer Res Treat; 2005; 89 Suppl 1():S17-26. PubMed ID: 15770535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.